Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Blood|August 24, 2010
Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaBrian Parkin, Harry Erba, Peter Ouillette, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid LeukemiaNiveditha Ravindra, Justin Lack, Clifton L Dalgard, et al.
Blood|August 16, 2011
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesJohn Magenau, Hiromi Tobai, Attaphol Pawarode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2010
NF1 inactivation in adult acute myelogenous leukemiaBrian Parkin, Peter Ouillette, Yin Wang, et al.
JCO Precision Oncology|October 31, 2019
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial IntelligenceAziz Nazha, Mikkael A Sekeres, Rafael Bejar, et al.
Haematologica|October 13, 2022
A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemiaKeith W Pratz, Jason Kaplan, Moshe Levy, et al.
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
Leukemia|July 18, 2021
Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202Amy S Ruppert, Allison M Booth, Wei Ding, et al.
Blood Advances|August 8, 2020
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adultsMikkael A Sekeres, Gordon Guyatt, Gregory Abel, et al.
Blood|January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraSimon Mantha, Debra A Goldman, Sean M Devlin, et al.
Pageof 4